Association between dispensing channel and medication adherence among Medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol

Journal of Managed Care Pharmacy

Volumn 20, Issue 8, 2014, Pages 851-861

  Iyengar, Reethi N ^a   Balagere, Dhanur S ^a   Henderson, Rochelle R ^a   LeFrancois, Abbey L ^a   Rabbitt, Rebecca M ^a   Frazee, Sharon Glave ^a  

^a Express Scripts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRESCRIPTION; BEHAVIOR ASSESSMENT; PHARMACY; RETROSPECTIVE STUDY; BLOOD; ECONOMICS; HEALTH CARE DELIVERY; INSURANCE; PROCEDURES; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; CHOLESTEROL; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSURANCE BENEFITS; MALE; MEDICARE; MEDICARE PART D; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; PHARMACIES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84904859229     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.8.851     Document Type: Article

References (40)

1. Centers for Medicare & Medicaid Services. Chronic conditions among Medicare beneficiaries. Chartbook: 2012 ed. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/2012Chartbook.pdf. Accessed May 21, 2014.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
3. Brunton SA. Improving medication adherence in chronic disease management. J Fam Pract. 2011;60(4 Suppl):S1-S8.
4. Blanchard J, Madden JM, Ross-Degnan D, Gresenz CR, Soumerai SB. The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries. Ann Emerg Med. 2013;62(5):475-85.
5. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-49.
6. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22(4):220-29.
7. Albert NM. Improving medication adherence in chronic cardiovascular disease. Crit Care Nurse. 2008;28(5):54-64.
8. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
9. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med. 1997;157(17):1921-29.
10. New England Healthcare Institute. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. August 12, 2009. Available at: http://www.nehi.net/publications/17-thinking-outside-the-pillbox-a-system-wide-approach-to-improving-patientmedication-adherence-for-chronic-disease/view. Accessed May 21, 2014.
11. Dall TM, Blanchard TD, Gallo PD, Semilla AP. The economic impact of Medicare Part D on congestive heart failure. Am J Manag Care. 2013; 19(6 Suppl):S97-S100.
12. Stuart B, Loh FE, Roberto P, Miller LM. Increasing Medicare Part D enrollment in medication therapy management could improve health and lower costs. Health Aff (Millwood). 2013;32(7):1212-20.
13. Williams J, Steers WN, Ettner SL, Mangione CM, Duru OK. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care. 2013;51(2):193-98.
14. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries:prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-60. Available at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=7948.
15. Zhang Y, Baik SH, Lave JR. Effects of Medicare Part D coverage gap on medication adherence. Am J Manag Care. 2013;19(6):e214-e24.
16. Centers for Medicare & Medicaid Services. Closing the coverage gap-Medicare prescription drugs are becoming more affordable. Revised February 2014. Available at: http://www.medicare.gov/Pubs/pdf/11493.pdf. Accessed May 21, 2014.
17. Reid RO, Deb P, Howell BL, Shrank WH. Association between Medicare Advantage plan star ratings and enrollment. JAMA. 2013;309(3):267-74.
18. Zhang L, Zakharyan A, Stockl KM, Harada AS, Curtis BS, Solow BK. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes. J Med Econ. 2011;14(5):562-67.
19. Duru OK, Schmittdiel JA, Dyer WT, et al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;16(1):33-40.
20. Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care. 2012;50(8):685-91.
21. Carroll NV, Brusilovsky I, York B, Oscar R. Comparison of costs of community and mail service pharmacy. J Am Pharm Assoc (2003). 2005;45(3):336-43.
22. Visaria J, Frazee SG, Devine ST. Asthma controller adherence in mail order pharmacy compared with retail pharmacy. Am J Pharm Benefits. 2012;4(3):e73-e80.
23. Schmittdiel JA, Karter AJ, Dyer WT, Chan J, Duru OK. Safety and effectiveness of mail order pharmacy use in diabetes. Am J Manag Care. 2013;19(11):882-87.
24. Khandelwal N, Duncan I, Rubinstein E, et al. Medication adherence for 90-day quantities of medication dispensed through retail and mail order pharmacies. Am J Manag Care. 2011;17(11):e427-e34.
25. Liberman JN, Girdish C. Recent trends in the dispensing of 90-daysupply prescriptions at retail pharmacies: implications for improved convenience and access. Am Health Drug Benefits. 2011;4(2):95-100.
26. Brennan TA, Dollear TJ, Hu M, et al. An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients. Health Aff (Millwood). 2012;31(1):120-29.
27. Iyengar R, Henderson R, Visaria J, Frazee SG. Dispensing channel and medication adherence: evidence across 3 therapy classes. Am J Manag Care. 2013;19(10):798-804.
28. Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118(3):309-18.
29. Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Med Care. 2010;48(6 Suppl):S114-S20.
30. Patrick AR, Shrank WH, Glynn RJ, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011;14(4):513-20.
31. U.S. Department of Health and Human Services. Basic HHS policy for protection of human research subjects, 45 C.F.R. Part 46 (2009).
32. Wu EQ, Johnson S, Beaulieu N, et al. Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients. Curr Med Res Opin. 2010;26(1):61-69.
33. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728-40. Available at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8250.
34. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46(11):1125-33.
35. U.S. Census Bureau. Metropolitan and micropolitan statistical areas main. Revised May 6, 2013. Available at: http://www.census.gov/population/metro/. Accessed May 21, 2014.
36. Janis IB, Nock MK. Behavioral forecasts do not improve the prediction of future behavior: a prospective study of self-injury. J Clin Psychol. 2008;64(10):1164-74.
37. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-54.
38. Samaras K, Campbell LV, Chisholm DJ. Can the effectiveness of physical activity programs be improved? Response to Clark. Diabetes Care. 1998;21(1):195-96.
39. Giannetti V. Adherence to therapeutic regimens. Res Social Adm Pharm. 2005;1(3):375-77.
40. Shay LE. A concept analysis: adherence and weight loss. Nurs Forum. 2008;43(1):42-52.